It is relevant to note that other studies of total plasma ACE2 levels failed to report changes in SARS-CoV-2 infected individuals (30–33) or to discriminate levels regarding the prognosis or mortality of COVID-19 patients (34). This evidence concerns the gene ACE2 and COVID-19.